S-Adenosylmethionine

catechol-O-methyltransferase ; Homo sapiens







71 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 32691671 Prospecting for new catechol-O-methyltransferase (COMT) inhibitors as a potential treatment for Parkinson's disease: a study by molecular dynamics and structure-based virtual screening. 2021 Oct 2
2 34027136 Interaction of silver nanoparticles with catechol O-methyltransferase: Spectroscopic and simulation analyses. 2021 Jul 1
3 34679357 Role of COMT V158M Polymorphism in the Development of Dystonia after Administration of Antipsychotic Drugs. 2021 Sep 29 2
4 31708229 Neurological and psychiatric management using COMT inhibitors: A review. 2020 Jan 1
5 31869215 Metabolic-Pathway-Oriented Screening Targeting S-Adenosyl-l-methionine Reveals the Epigenetic Remodeling Activities of Naturally Occurring Catechols. 2020 Jan 8 2
6 32371482 Hydrogen deuterium exchange defines catalytically linked regions of protein flexibility in the catechol O-methyltransferase reaction. 2020 May 19 2
7 32378542 Crystal Structure of Catechol O-Methyltransferase Complexed with Nitecapone. 2020 8
8 32492152 Nano-second protein dynamics of key residue at Position 38 in catechol-O-methyltransferase system: a time-resolved fluorescence study. 2020 Oct 1 4
9 30935952 The extra virgin olive oil phenolic oleacein is a dual substrate-inhibitor of catechol-O-methyltransferase. 2019 Jun 1
10 30157632 Catalytic Reaction Mechanism in Native and Mutant Catechol- O-methyltransferase from the Adaptive String Method and Mean Reaction Force Analysis. 2018 Sep 27 1
11 27826992 The Val158Met polymorphism in COMT gene and cancer risk: role of endogenous and exogenous catechols. 2017 Feb 2
12 27939670 Identification and characterization of a catechol-o-methyltransferase cDNA in the catfish Heteropneustes fossilis: Tissue, sex and seasonal variations, and effects of gonadotropin and 2-hydroxyestradiol-17β on mRNA expression. 2017 May 15 1
13 27981425 1H, 15N, 13C backbone resonance assignments of human soluble catechol O-methyltransferase in complex with S-adenosyl-L-methionine and 3,5-dinitrocatechol. 2017 Apr 2
14 28448141 Correction to Design of Potent and Druglike Nonphenolic Inhibitors for Catechol O-Methyltransferase Derived from a Fragment Screening Approach Targeting the S-Adenosyl-l-methionine Pocket. 2017 May 11 1
15 27685665 Design of Potent and Druglike Nonphenolic Inhibitors for Catechol O-Methyltransferase Derived from a Fragment Screening Approach Targeting the S-Adenosyl-l-methionine Pocket. 2016 Nov 23 1
16 25159911 Linking electrostatic effects and protein motions in enzymatic catalysis. A theoretical analysis of catechol o-methyltransferase. 2015 Jan 22 2
17 25388538 Methyltransferases do not work by compression, cratic, or desolvation effects, but by electrostatic preorganization. 2015 Feb 2
18 26253436 Relationship between the catechol-O-methyl transferase Val108/158Met genotype and brain volume in treatment-naive major depressive disorder: Voxel-based morphometry analysis. 2015 Sep 30 2
19 24847974 A fragment-based approach to identifying S-adenosyl-l-methionine -competitive inhibitors of catechol O-methyl transferase (COMT). 2014 Jun 26 2
20 24450388 Inhibitors of catechol-O-methyltransferase in the treatment of neurological disorders. 2013 2
21 22349227 Catechol-O-methyltransferase in complex with substituted 3'-deoxyribose bisubstrate inhibitors. 2012 Mar 1
22 23056605 How metal substitution affects the enzymatic activity of catechol-o-methyltransferase. 2012 2
23 21304959 Epistasis between COMT and MTHFR in maternal-fetal dyads increases risk for preeclampsia. 2011 Jan 31 4
24 21538606 Molecular recognition at the active site of catechol-O-methyltransferase (COMT): adenine replacements in bisubstrate inhibitors. 2011 May 27 3
25 21904625 Structural mechanism of S-adenosyl methionine binding to catechol O-methyltransferase. 2011 1
26 21958159 Enzymatic methyl transfer: role of an active site residue in generating active site compaction that correlates with catalytic efficiency. 2011 Nov 2 4
27 21154325 [Association of genetic polymorphisms of COMT gene with psychiatric disorders]. 2010 Dec 2
28 18824331 Improvement of aggressive behavior and quality of life impairment following S-adenosyl-methionine (SAM-e) augmentation in schizophrenia. 2009 Jan 1
29 19077667 Identification of a novel haplotype of the human catechol-O-methyltransferase gene. 2009 Jan 2
30 18474266 The V108M mutation decreases the structural stability of catechol O-methyltransferase. 2008 Jul-Aug 2
31 18486144 Crystal structures of human 108V and 108M catechol O-methyltransferase. 2008 Jun 27 2
32 19020775 Characterization of a novel human catechol-O-methyl-transferase mutant with triplet point mutations. 2008 Dec 3
33 17724020 S-adenosylmethionine-dependent protein methylation in mammalian cytosol via tyrphostin modification by catechol-O-methyltransferase. 2007 Oct 19 1
34 17880176 Biochemical and molecular modeling studies of the O-methylation of various endogenous and exogenous catechol substrates catalyzed by recombinant human soluble and membrane-bound catechol-O-methyltransferases. 2007 Oct 2
35 17907785 NADPH-dependent covalent binding of [3H]paroxetine to human liver microsomes and S-9 fractions: identification of an electrophilic quinone metabolite of paroxetine. 2007 Nov 2
36 18064318 Catechol-O-methyltransferase genotype is associated with plasma total homocysteine levels and may increase venous thrombosis risk. 2007 Dec 2
37 16475806 The 108M polymorph of human catechol O-methyltransferase is prone to deformation at physiological temperatures. 2006 Feb 21 6
38 16618795 Comparative study of ortho- and meta-nitrated inhibitors of catechol-O-methyltransferase: interactions with the active site and regioselectivity of O-methylation. 2006 Jul 1
39 15614425 The COMT inhibitor, entacapone, reduces levodopa-induced elevations in plasma homocysteine in healthy adult rats. 2005 Sep 4
40 16045352 On the nature of the transition state in catechol O-methyltransferase. A complementary study based on molecular dynamics and potential energy surface explorations. 2005 Aug 3 1
41 16340382 Levodopa intake increases plasma levels of S-adenosylmethionine in treated patients with Parkinson disease. 2005 Nov-Dec 2
42 15124004 Variants in the catechol-o-methyltransferase (COMT) gene are associated with schizophrenia in Irish high-density families. 2004 Oct 2
43 12533089 Elevated plasma homocysteine levels in patients treated with levodopa: association with vascular disease. 2003 Jan 1
44 12842102 High-performance liquid chromatography determination of methionine adenosyltransferase activity using catechol-O-methyltransferase-coupled fluorometric detection. 2003 Aug 1 1
45 12075857 3-OMD and homocysteine plasma levels in parkinsonian patients. 2002 Feb 4
46 12450669 Separation methods for catechol O-methyltransferase activity assay: physiological and pathophysiological relevance. 2002 Dec 5 2
47 11223018 COMT-dependent protection of dopaminergic neurons by methionine, dimethionine and S-adenosylmethionine (SAM) against L-dopa toxicity in vitro. 2001 Mar 2 1
48 11577006 COMT genotype, micronutrients in the folate metabolic pathway and breast cancer risk. 2001 Oct 5
49 10692500 Catechol-O-methyltransferase inhibition attenuates levodopa toxicity in mesencephalic dopamine neurons. 2000 Mar 1
50 10950844 O-Methylation of tea polyphenols catalyzed by human placental cytosolic catechol-O-methyltransferase. 2000 Sep 2